Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of NCS-01 in Patients With Acute Ischemic Stroke
Sponsor: NC Medial Research Inc
Summary
This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
Official title: A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
16
Start Date
2020-02-27
Completion Date
2028-10
Last Updated
2025-09-11
Healthy Volunteers
No
Conditions
Interventions
NCS-01
single infusion
Locations (1)
University of Miami
Miami, Florida, United States